GEMS sees healthy growth in 1999

Article

GE Medical Systems garnered praise when GE announced its fiscal 1999 financial results. The Fairfield, CT, conglomerate said that acceptance of its Six Sigma-designed products caused its medical business to grow by 25% for the year. Six Sigma is

GE Medical Systems garnered praise when GE announced its fiscal 1999 financial results. The Fairfield, CT, conglomerate said that acceptance of its Six Sigma-designed products caused its medical business to grow by 25% for the year. Six Sigma is GE’s quality improvement program, which is being applied company-wide.

Many of GE’s 1999 accomplishments culminated at last December’s RSNA conference. There it completed its acquisition of OEC Medical Systems and introduced a new high-field open MRI system, GE Sigma OpenSpeed. Following the meeting, GE won a recommendation from a Food and Drug Administration panel for clearance of its digital mammography unit, Senographe 2000D (SCAN 1/12/00, 11/24/99, and 9/18/99).

For the year, GE reported revenues of $112 billion, up 11% compared with $100 billion in 1998. The company posted earnings of $10.7 billion, up 15% from 1998’s $9.3 billion. GE did not break out sales and earnings figures for GE Medical Systems, other than to report on the business’s overall growth.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.